Three-point technique of fat quantification of muscle tissue as a marker of disease progression in Duchenne muscular dystrophy: preliminary study.
暂无分享,去创建一个
Vicente Gilsanz | Stefan Bluml | T. Wren | S. Bluml | L. Tseng-Ong | V. Gilsanz | Tishya A L Wren | Linda Tseng-Ong
[1] Vicente Gilsanz,et al. Fat quantification using three-point dixon technique: in vitro validation. , 2005, Academic radiology.
[2] R. Abresch,et al. Serial manual muscle testing in Duchenne muscular dystrophy. , 1993, Archives of physical medicine and rehabilitation.
[3] V. Dubowitz,et al. Quantitation of muscle function in children: A prospective study in duchenne muscular dystrophy , 1982, Muscle & nerve.
[4] Anita Beelen,et al. Predictive Factors of Cessation of Ambulation in Patients with Duchenne Muscular Dystrophy , 2002, American journal of physical medicine & rehabilitation.
[5] R. Adams,et al. Diseases of Muscle: Pathological Foundations of Clinical Myology , 1985 .
[6] G. Liu,et al. Duchenne muscular dystrophy: MR grading system with functional correlation. , 1993, Radiology.
[7] C. Reimers,et al. Calf enlargement in neuromuscular diseases: a quantitative ultrasound study in 350 patients and review of the literature , 1996, Journal of the Neurological Sciences.
[8] R. Abresch,et al. Profiles of neuromuscular diseases. Becker's muscular dystrophy. , 1995, American journal of physical medicine & rehabilitation.
[9] R. Abresch,et al. Erratum: Profiles of neuromuscular diseases: Duchenne muscular dystrophy (American Journal of Physical Medicine and Rehabilitation (1995) 74 (S70- S92)) , 1996 .
[10] N Roberts,et al. Estimation of body composition in muscular dystrophy by MRI and stereology , 2000, Journal of Magnetic Resonance Imaging.
[11] Akinori Nakamura,et al. Evaluation of dystrophic dog pathology by fat‐suppressed T2‐weighted imaging , 2009, Muscle & nerve.
[12] Yen-Mou Lu,et al. Measurement of the Functional Status of Patients with Different Types of Muscular Dystrophy , 2009, The Kaohsiung journal of medical sciences.
[13] J. Miller,et al. Clinical investigation in duchenne dystrophy: 2. Determination of the “power” of therapeutic trials based on the natural history , 1983, Muscle & nerve.
[14] Y. Tateno,et al. Protron spin‐lattice relaxation time of duchenne dystrophy skeletal muscle by magnetic resonance imaging , 1988, Muscle & nerve.
[15] M. Brooke,et al. Clinical trial in duchenne dystrophy. I. The design of the protocol , 1981, Muscle & nerve.
[16] H. Gruber,et al. Neuromuscular diseases: evaluation with high-frequency sonography. , 1990 .
[17] A. Connolly,et al. Compositional analysis of muscle in boys with Duchenne muscular dystrophy using MR imaging , 2005, Skeletal Radiology.
[18] K. Nayak,et al. Change in the proton T1 of fat and water in mixture , 2010, Magnetic resonance in medicine.
[19] G. Bentley,et al. A randomized controlled trial of early surgery in duchenne muscular dystrophy , 1992, Neuromuscular Disorders.
[20] Eric P. Hoffman,et al. Dystrophin: The protein product of the duchenne muscular dystrophy locus , 1987, Cell.
[21] F. Mastaglia,et al. Morphological changes in dystrophic muscle. , 1980, British medical bulletin.
[22] T. Khurana,et al. Therapeutics for Duchenne muscular dystrophy: current approaches and future directions , 2004, Journal of Molecular Medicine.
[23] M. Geffner,et al. Obesity and fat quantification in lean tissues using three-point Dixon MR imaging , 2005, Pediatric Radiology.
[24] S. Leeman,et al. Quantitative Sonography of Muscle , 1989 .
[25] S. Giannini,et al. Upper limb bone mineral density and body composition measured by peripheral quantitative computed tomography in right-handed adults: The role of the dominance effect , 2009, Journal of endocrinological investigation.
[26] Benjamin S. Aribisala,et al. MR imaging in Duchenne muscular dystrophy: Quantification of T1‐weighted signal, contrast uptake, and the effects of exercise , 2009, Journal of magnetic resonance imaging : JMRI.
[27] Walteil J. Murphy,et al. MRI of normal and pathologic skeletal muscle. , 1986, AJR. American journal of roentgenology.
[28] C. Dani,et al. Enhancement of myogenic and muscle repair capacities of human adipose-derived stem cells with forced expression of MyoD. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.
[29] S. Zuberi,et al. Muscle ultrasound in the assessment of suspected neuromuscular disease in childhood , 1999, Neuromuscular Disorders.
[30] R. Kapsa,et al. For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group. Molecular Pathology of Dmd Novel Therapies for Dmd Novel Therapies for Duchenne Muscular Dystrophy , 2022 .
[31] W. T. Dixon. Simple proton spectroscopic imaging. , 1984, Radiology.
[32] J. Tidball,et al. Skipping to new gene therapies for muscular dystrophy , 2003, Nature Medicine.
[33] Arend Heerschap,et al. Quantitative MR imaging of individual muscle involvement in facioscapulohumeral muscular dystrophy , 2009, Neuromuscular Disorders.
[34] I. Suramo,et al. High‐frequency ultrasonography of skeletal muscle in children with neuromuscular disease. , 1988, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.
[35] J. Miller,et al. Duchenne muscular dystrophy , 1989, Neurology.